Analogs of JHU75528, a PET ligand for imaging of cerebral cannabinoid receptors (CBI): Development of ligands with optimized lipophilicity and binding affinity

被引:13
作者
Fan, Hong [1 ]
Kotsikorou, Evangelia [2 ]
Hoffman, Alexander F. [3 ]
Ravert, Hayden T. [1 ]
Holt, Daniel [1 ]
Hurst, Dow P. [2 ]
Lupica, Carl R. [3 ]
Reggio, Patricia H. [2 ]
Dannals, Robert F. [1 ]
Horti, Andrew G. [1 ]
机构
[1] Johns Hopkins Univ Hosp, Sch Med, Dept Radiol, Div Nucl Med,PET Ctr, Baltimore, MD 21287 USA
[2] Univ N Carolina, Dept Chem & Biochem, Ctr Drug Discovery, Greensboro, NC 27402 USA
[3] NIDA, Intramural Res Program, Cellular Neurobiol Branch, Electrophysiol Res Unit, Baltimore, MD 21224 USA
关键词
Cannabinoid receptor; Carbon-11; JHU75528; Rimonabant; Positron emission tomography; Molecular modeling; Receptor docking; PREFRONTAL CORTEX; NUCLEUS-ACCUMBENS; F-18; SR144385; BRAIN; RADIOLIGANDS; LOCALIZATION; ANTAGONISTS; AGONIST; PHARMACOLOGY; RADIOTRACER;
D O I
10.1016/j.ejmech.2008.03.040
中图分类号
R914 [药物化学];
学科分类号
100701 ;
摘要
Cyano analogs of Rimonabant with high binding affinity for the cerebral cannabinoid receptor (CB1) and with optimized lipophilicity have been synthesized as potential positron emission tomography (PET) ligands. The best ligands of the series are optimal targets for the future radiolabeling with PET isotopes and in vivo evaluation as radioligands with enhanced properties for PET imaging of CB1 receptors in human subjects. Extracellular electrophysiological recordings in rodent brain slices demonstrated that JHU75528, 4, the lead compound of the new series, has functional CB antagonist properties that are consistent with its structural relationship to Rimonabant. Molecular modeling analysis revealed an important role of the binding of the cyano group with the CB1 binding pocket. (C) 2008 Elsevier Masson SAS. All rights reserved.
引用
收藏
页码:593 / 608
页数:16
相关论文
共 56 条
  • [21] International Union of Pharmacology. XXVII. Classification of cannabinoid receptors
    Howlett, AC
    Barth, F
    Bonner, TI
    Cabral, G
    Casellas, P
    Devane, WA
    Felder, CC
    Herkenham, M
    Mackie, K
    Martin, BR
    Mechoulam, R
    Pertwee, RG
    [J]. PHARMACOLOGICAL REVIEWS, 2002, 54 (02) : 161 - 202
  • [22] Blockade of effects of smoked marijuana by the CBl-selective cannabinoid receptor antagonist SR141716
    Huestis, MA
    Gorelick, DA
    Heishman, SJ
    Preston, KL
    Nelson, RA
    Moolchan, ET
    Frank, RA
    [J]. ARCHIVES OF GENERAL PSYCHIATRY, 2001, 58 (04) : 322 - 328
  • [23] Upregulation of CB1 receptors and agonist-stimulated [35S]GTPγS binding in the prefrontal cortex of depressed suicide victims
    Hungund, BL
    Vinod, KY
    Kassir, SA
    Basavarajappa, BS
    Yalamanchili, R
    Cooper, TB
    Mann, JJ
    Arango, V
    [J]. MOLECULAR PSYCHIATRY, 2004, 9 (02) : 184 - 190
  • [24] PI-PI-INTERACTIONS - THE GEOMETRY AND ENERGETICS OF PHENYLALANINE PHENYLALANINE INTERACTIONS IN PROTEINS
    HUNTER, CA
    SINGH, J
    THORNTON, JM
    [J]. JOURNAL OF MOLECULAR BIOLOGY, 1991, 218 (04) : 837 - 846
  • [25] Biarylpyrazole inverse agonists at the cannabinoid CB1 receptor: Importance of the C-3 carboxamide oxygen/lysine3.28(192) interaction
    Hurst, Dow
    Umejiego, Uju
    Lynch, Diane
    Seltzman, Herbert
    Hyatt, Steven
    Roche, Michael
    McAllister, Sean
    Fleischer, Daniel
    Kapur, Ankur
    Abood, Mary
    Shi, Shanping
    Jones, Jannie
    Lewis, Deborah
    Reggio, Patricia
    [J]. JOURNAL OF MEDICINAL CHEMISTRY, 2006, 49 (20) : 5969 - 5987
  • [26] N-(Piperidin-1-yl)-5-(4-chlorophenyl)-1-(2,4-dichlorophenyl)-4-methyl-1H-pyrazole-3-carboxamide (SR141716A) interaction with LYS 3.28(192) is crucial for its inverse agonism at the cannabinoid CB1 receptor
    Hurst, DP
    Lynch, DL
    Barnett-Norris, J
    Hyatt, SM
    Seltzman, HH
    Zhong, M
    Song, ZH
    Nie, JJ
    Lewis, D
    Reggio, PH
    [J]. MOLECULAR PHARMACOLOGY, 2002, 62 (06) : 1274 - 1287
  • [27] Radiosynthesis of O-[11C]methyl-L-tyrosine and O-[18F]fluoromethyl-L-tyrosine as potential PET tracers for imaging amino acid transport
    Iwata, R
    Furumoto, S
    Pascali, C
    Bogni, A
    Ishiwata, K
    [J]. JOURNAL OF LABELLED COMPOUNDS & RADIOPHARMACEUTICALS, 2003, 46 (06) : 555 - 566
  • [28] JEWETT DM, 1992, APPL RADIAT ISOTOPES, V43, P1383
  • [29] Synthesis, structure-activity relationship, and evaluation of SR141716 analogues: Development of central cannabinoid receptor ligands with lower lipophilicity
    Katoch-Rouse, R
    Pavlova, OA
    Caulder, T
    Hoffman, AF
    Mukhin, AG
    Horti, AG
    [J]. JOURNAL OF MEDICINAL CHEMISTRY, 2003, 46 (04) : 642 - 645
  • [30] Synthesis of N-(piperidin-1-yl)-5-(4-methoxyphenyl)-1-(2-chlorophenyl)-4-[18F]fluoro-1H-pyrazole-3-carboxamide by nucleophilic [18F] fluorination:: a PET radiotracer for studying CB1 cannabinoid receptors
    Katoch-Rouse, R
    Horti, AG
    [J]. JOURNAL OF LABELLED COMPOUNDS & RADIOPHARMACEUTICALS, 2003, 46 (01) : 93 - 98